Healthways Inc. (HWAY) Upgraded by Zacks to OUTPERFORM

Zacks Investment Research upgraded shares of Healthways Inc. (HWAY) from NEUTRAL to OUTPERFORM on October 05, 2012, with a target price of $14.00.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

To get a free copy of the research report on Healthways Inc. (HWAY),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .